Access
This article is part of Nature's premium content.
Published online 24 October 2007 | Nature 449, 952-953 (2007) | doi:10.1038/449952b
News
Health official speaks out about row over drug critic
Fresh light is shed on dispute over diabetes pill.
The former drug-company official who heads global health at the Bill and Melinda Gates Foundation has broken his silence over accusations of acting inappropriately eight years ago, when a physician raised questions about the safety of one of the company's drugs.
The drug, Avandia (rosiglitazone), has come under scrutiny this year after two meta-analyses
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
